Published in J Cyst Fibros on April 28, 2008
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med (2011) 8.73
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med (2013) 1.73
Fine-scale patterns of population stratification confound rare variant association tests. PLoS One (2013) 1.18
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease. Clin Investig (Lond) (2015) 1.13
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis. EBioMedicine (2014) 0.95
Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect Microbiol (2011) 0.94
The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res (2011) 0.93
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell (2016) 0.92
Next-generation community genetics for low- and middle-income countries. Genome Med (2012) 0.91
High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency. J Clin Microbiol (2011) 0.88
Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. Drug Des Devel Ther (2013) 0.87
The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels. Dis Model Mech (2014) 0.86
Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland. Multidiscip Respir Med (2015) 0.85
Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis (2012) 0.83
The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children. BMC Pulm Med (2016) 0.82
Expanded newborn screening in Greece: 30 months of experience. J Inherit Metab Dis (2010) 0.82
Minimum data set for cystic fibrosis registry: a case study in iran. Acta Inform Med (2015) 0.81
CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients. PLoS One (2014) 0.81
Can Cystic Fibrosis Patients Finally Catch a Breath With Orkambi? Clin Pharmacol Ther (2016) 0.81
Validation of a semiconductor next-generation sequencing assay for the clinical genetic screening of CFTR. Mol Genet Genomic Med (2015) 0.79
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. Trials (2012) 0.79
Potential of anti-inflammatory treatment for cystic fibrosis lung disease. J Inflamm Res (2010) 0.78
18q deletion in a cystic fibrosis infant, increased morbidity and challenge for correct treatment choices: a case report. Ital J Pediatr (2011) 0.78
Notable contribution of large CFTR gene rearrangements to the diagnosis of cystic fibrosis in fetuses with bowel anomalies. Eur J Hum Genet (2010) 0.78
Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy. Eur J Hum Genet (2012) 0.77
Long term follow-up of a tobacco prevention and cessation program in cystic fibrosis patients. Adicciones (2016) 0.76
Validation of antibody reagents for mucin analysis in chronic inflammatory airway diseases. MAbs (2016) 0.75
Psychosocial distress and functioning of Greek youth with cystic fibrosis: a cross-sectional study. Biopsychosoc Med (2014) 0.75
Analysis of Cystic Fibrosis in Federation of Bosnia and Herzegovina. Med Arch (2015) 0.75
Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation Analysis. PLoS One (2016) 0.75
European Non-Communicable Respiratory Disease Research, 2002-13: Bibliometric Study of Outputs and Funding. PLoS One (2016) 0.75
Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations. Food Nutr Res (2011) 0.75
Evolving serodiagnostics by rationally designed peptide arrays: the Burkholderia paradigm in Cystic Fibrosis. Sci Rep (2016) 0.75
Evaluating performance in sweat testing in medical biochemistry laboratories in Croatia. Biochem Med (Zagreb) (2017) 0.75
Cystic fibrosis prevalence among a group of high-risk children in the main referral children hospital in Iran. J Educ Health Promot (2017) 0.75
Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group. Eur Arch Otorhinolaryngol (2014) 0.75
Folding correction of ABC-transporter ABCB1 by pharmacological chaperones: a mechanistic concept. Pharmacol Res Perspect (2017) 0.75